رفتن به محتوا

تداخل‌های دارویی

Abciximab + Ticagrelor

شدت: شدید

Abciximab and Ticagrelor: major interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Ticagrelor with a glycoprotein IIb/IIIa inhibitor produces strong combined platelet inhibition and increases the risk of major bleeding. This pairing is sometimes used deliberately during PCI but requires care.

معنای این تداخل به زبان ساده

Abciximab and Ticagrelor can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Abciximab belongs to Cardiovascular; Ticagrelor belongs to Cardiovascular.

سطح شواهد: High

چرا رخ می‌دهد

Additive antiplatelet effects via P2Y12 blockade and GP IIb/IIIa receptor blockade.

اقدام لازم

Use only when clearly indicated, such as during PCI, and monitor hemoglobin, platelet count and bleeding signs. Limit duration of the GP IIb/IIIa infusion.

از داروساز چه بپرسید

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Abciximab و Ticagrelor، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Abciximab with Ticagrelor?

MediHelp rates the interaction as major. Abciximab and Ticagrelor can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ticagrelor with a glycoprotein IIb/IIIa inhibitor produces strong combined platelet inhibition and increases the risk of major bleeding. This pairing is sometimes used deliberately during PCI but requires care.

How serious is the interaction between Abciximab and Ticagrelor?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use only when clearly indicated, such as during PCI, and monitor hemoglobin, platelet count and bleeding signs. Limit duration of the GP IIb/IIIa infusion.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود